🌐 If the text on this page is hard to understand, right‑click and select “Translate” or use your browser’s translation settings.
Put your Business English for life sciences to the test with a quiz below.
A. A new drug shows a 90% reduction in blood pressure in a clinical trial.
B. The same drug reduces blood pressure by 70% on average in real-world patients, considering factors like adherence and comorbidities.
C. A healthcare system that delivers quality care while minimising costs and reducing wait times.
Here are the correct matches for the words and sentences:
A. efficacy: a new drug shows a 90% reduction in blood pressure in a clinical trial.
B. effectiveness: the same drug reduces blood pressure by 70% on average in real-world patients, considering factors like adherence and comorbidities.
C. efficiency: a healthcare system that delivers quality care while minimising costs and reducing wait times.
advancement
recurrence
groundbreaking
novel
transformative
enrol
eradicate
survival
pioneered
cutting-edge
A. the state or fact of continuing to live or exist
B. new and unusual in an interesting way
C. to completely destroy or put an end to something
D. a development or improvement
E. developed or first used a new method or technology
F. the fact of something happening again, especially a medical condition
G. to officially join a course, institution, or clinical trial
H. causing a marked change in a person or thing
I. the very latest stage in the development of something
J. highly innovative or original; a new approach
Here are the correct matches for the terms and definitions:
advancement: D
Explanation: 'Advancement' refers to a development or improvement, such as a new treatment representing an advancement in patient care.
recurrence: F
Explanation: 'recurrence' specifically denotes something happening again, often used in the context of a disease returning after a period of remission.
groundbreaking: J
Explanation: 'groundbreaking' describes something that is highly innovative and original, often establishing a completely new approach in its field.
novel: B
Explanation: 'novel' refers to something that is new and interestingly unusual, such as a novel mechanism of action for a drug.
transformative: H
Explanation: 'transformative' is used for something that causes a significant and fundamental change, for example a therapy that transforms patient outcomes.
enrol: G
Explanation: 'enrol' means to officially register or join something, most commonly used in our industry for patients joining a clinical trial.
eradicate: C
Explanation: 'eradicate' means to destroy completely, a term often used with the goal to eradicate a disease.
survival: A
Explanation: 'survival' simply means the state of continuing to live or exist, frequently measured in clinical trials as overall survival.
pioneered: E
Explanation: 'pioneered' indicates that an individual or company was the first to develop or use a specific method or technology.
cutting-edge: I
Explanation: 'cutting-edge' describes something that is at the absolute forefront of technological or scientific development.
All clinical sites must adhere strictly ______ the agreed standard-of-care protocols.
The new compound has demonstrated high levels ______ effectiveness ______ studies.
Headaches and nausea are common adverse events associated ______ this treatment.
The development ______ the vaccine was the result ______ a collaboration ______ our company and a leading research institute.
This new therapy is indicated ______ patients presenting ______ moderate to severe symptoms.
Here are the correct prepositions:
All clinical sites must adhere strictly to the agreed standard-of-care protocols.
The new compound has demonstrated high levels of effectiveness in studies.
Headaches and nausea are common adverse events associated with this treatment.
The development of the vaccine was the result of a collaboration between our company and a leading research institute.
This new therapy is indicated for patients presenting with moderate to severe symptoms.
Read the text below, then answer the questions that follow
In a significant advancement for the field of oncology, a groundbreaking Phase I/II clinical trial is currently underway to evaluate a novel mRNA-based cancer vaccine for patients presenting with advanced head and neck squamous cell carcinoma. This strategic initiative is a collaboration between the National Health Service (NHS), the publicly funded healthcare system of the United Kingdom, and a life sciences company BioNTech. It is designed to streamline patient recruitment and accelerate trial timelines. The trial, known as AHEAD-MERIT (BNT113-01), aims to enrol a patient cohort of over 100 individuals across 15 NHS hospitals in England.
The therapeutic modality employs messenger RNA technology to elicit a targeted immune response. It specifically instructs the patient's immune system to recognise and eradicate cancer cells that express two proteins associated with the human papillomavirus (HPV-16). This viral strain is a key driver of approximately 95% of HPV-related head and neck cancers. Given that advanced-stage cases often have a high rate of recurrence and a prognosis of less than 50% two-year survival, this vaccine represents a potentially transformative intervention.
The NHS has pioneered the "Cancer vaccine launch pad", a platform designed to efficiently match eligible patients with cutting-edge vaccine trials. This innovative approach has already demonstrated its effectiveness in studies for other cancer types, significantly expediting patient access to investigational therapies. Stakeholders are optimistic that this latest trial will provide a renewed sense of hope and establish a viable alternative to existing standard-of-care protocols.
While mRNA cancer vaccine research advances in the UK, concerns have emerged in the US. Recent cancellations of federal contracts for mRNA infectious disease projects by the Department of Health and Human Services (HHS) have raised concerns about potential spillover effects on oncology research. Though not a direct game-stopper, experts warn that disruptions to shared infrastructure and talent pools, critical for both infectious disease and cancer studies, could delay breakthroughs in cancer treatment. This contrast highlights how regulatory and funding decisions directly affect the pace of medical innovation.
References
Based on the text provided, decide whether the following statements are true or false:
The AHEAD-MERIT trial is designed to test a new mRNA-based cancer vaccine that will directly shrink tumours.
The collaboration between the NHS and BioNTech aims to make it quicker and easier to sign up patients for the trial and finish the study faster.
“Cancer vaccine launch pad” is a platform designed by BioNTech.
In the US, cancer research will not be disrupted by recent cancellations of federal contracts for mRNA as these affect infectious disease projects only.
Here are the correct answers with explanations:
False. The trial is designed to test a vaccine that instructs the immune system to fight cancer cells, not a drug that directly shrinks tumours.
True. The text states that this strategic initiative "is designed to streamline patient recruitment and accelerate trial timelines”.
False. The text states that it was the NHS which has pioneered the "Cancer vaccine launch pad".
False. The text warns that disruptions to shared infrastructure and talent pools could delay breakthroughs in cancer treatment.
For each question, choose the single best answer
1. Based on the text, what concern have experts raised regarding the cancellation of federal contracts?
A. The decision will lead to a direct and immediate halt in all oncology research.
B. The shared resources for both infectious disease and cancer research may be disrupted, slowing down the development of cancer treatments.
C. The US Department of Health and Human Services is no longer interested in funding any new vaccine projects.
2. The text states that the viral strain HPV-16 is significant because it is:
A. the sole cause of all head and neck cancers
B. a key driver of nearly all HPV-related head and neck cancers
C. the main reason for the high recurrence rate of advanced-stage cancers
3. When the text (last paragraph) mentions "potential spillover effects on oncology research," it is referring to:
A. unintended negative consequences spreading from one area of research to another
B. extra funding or resources from infectious disease research may be re-directed to cancer research
C. new technologies for infectious disease projects will be adapted and used to advance cancer research
4. In the context of the text (last paragraph), “a game-stopper" refers to
A. the cancellations of federal contracts
B. the Department of Health and Human Services (HHS)
C. potential spillover effects on infectious disease research
Here are the correct answers with explanations:
A. is incorrect: the text clarifies that the decision "does not directly halt all oncology research."
B. is the correct answer: the text explicitly states that "experts have expressed concern about a potential chilling effect" and that "the shared infrastructure and talent pool... could face indirect disruptions, potentially impacting the speed of development for cancer treatments."
C. is incorrect: while the text mentions that contracts for infectious disease projects were cancelled, the experts' specific concern highlighted in the passage is the negative knock-on effect this will have on oncology research, not the overall funding policy.
A. is correct: the text directly states that the viral strain HPV-16 "is a key driver of approximately 95% of HPV-related head and neck cancers."
B. is incorrect: the text specifies it is a driver of HPV-related cancers, not all head and neck cancers, and the figure is approximately 95%, not 100%.
C. is incorrect: the text links the high recurrence rate to advanced-stage cases in general, but it doesn't state that HPV-16 is the direct cause of this recurrence rate.
A. is correct: in the context of the passage, "spillover effects" means problems in one area (infectious disease) could spread and harm another (oncology) by disrupting shared infrastructure and talent pools
B. is incorrect: it misinterprets the meaning of "spillover" by suggesting a positive transfer of resources, which is the opposite of the context
C. is incorrect: it suggests a positive transfer of benefits, which is not what the passage is about
A. is correct: the cancellations of federal contracts are the potential "game-stopper," but the author clarifies they will not completely stop progress
B. is incorrect because the HHS is the organisation that made the cancellations; it is not the event (“game-stopper”) itself
C. is incorrect because the spillover effects are the result of the cancellations, not the "game-stopper" itself
A. I don't know.
B. The situation is very serious.
C. Do as I say.
D. That’s not the best way to do it.
Suggested rephrased statements:
A. I'm not entirely sure.
B. The situation is a bit tricky.
C. I would suggest…
D. That's certainly one way to do it.
Strengthen your ability to lead and collaborate with 1:1 sessions tailored to your goals. Get in touch to discuss your needs and build your skills in:
communicating with clarity and authority
understanding complex medical texts
collaborating effectively in global teams.
Equip your team with the language for success. I offer customised programmes to build team-wide proficiency in:
impactful business communication
effective cross-cultural collaboration
precise regulatory and scientific language.
Contact me to learn more.
Improve your vocabulary and other language skills with engaging lessons based on medical news and stories. New resources are published regularly, so you always have something fresh to learn. Study at your own pace, anytime and anywhere.
Practise your speaking skills in a supportive group setting. Choose from a variety of clubs for like-minded learners pursuing similar goals, or start your own group with friends or colleagues.